Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew S deLemos

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Digestive Diseases and Sciences|March 23, 2016
Amoxicillin-Clavulanate-Induced Liver InjuryAndrew S deLemos, Marwan Ghabril, Don C Rockey, et al.
Journal of Gastroenterology and Hepatology|December 23, 2025
Modern Diets, Metabolic Inequity, and Race-Ethnic Disparities: Unraveling the Associations With MASLD and Cancer RiskArunkumar Krishnan, Kunal C Kadakia, Sean Richard Rudnick, et al.
Human Gene Therapy|December 29, 2017
Adeno-Associated Virus Serotype 2 Vector-Mediated Reintroduction of microRNA-19b Attenuates Hepatic FibrosisElizabeth Brandon-Warner, Jennifer H Benbow, Jacob H Swet, et al.
Molecular and Cellular Biology|November 14, 2007
Parvin-beta inhibits breast cancer tumorigenicity and promotes CDK9-mediated peroxisome proliferator-activated receptor gamma 1 phosphorylationCameron N Johnstone, Perry S Mongroo, A Sophie Rich, et al.
Digestive Diseases and Sciences|January 14, 2018
Analysis of Plasma Tenascin-C in Post-HCV Cirrhosis: A Prospective StudyJennifer H Benbow, April D Elam, Krista L Bossi, et al.
World Journal of Hepatology|March 22, 2017
Risk factors for hepatocellular carcinoma in cirrhosis due to nonalcoholic fatty liver disease: A multicenter, case-control studyKathleen E Corey, Samer Gawrieh, Andrew S deLemos, et al.
Journal of Hepatology|September 6, 2021
Proof-of-concept study to evaluate the safety and efficacy of saroglitazar in patients with primary biliary cholangitisRaj Vuppalanchi, Stephen H Caldwell, Nikolaos Pyrsopoulos, et al.
The American Journal of Pathology|November 26, 2015
Diet-Induced Obesity Enhances Progression of Hepatocellular Carcinoma through Tenascin-C/Toll-Like Receptor 4 SignalingJennifer H Benbow, Kyle J Thompson, Heidi L Cope, et al.
Science Translational Medicine|November 22, 2013
Pharmacological inhibition of a microRNA family in nonhuman primates by a seed-targeting 8-mer antimiRVeerle Rottiers, Susanna Obad, Andreas Petri, et al.
Gastroenterology|June 4, 2023
Procedural-Related Bleeding in Hospitalized Patients With Liver Disease (PROC-BLeeD): An International, Prospective, Multicenter Observational StudyNicolas M Intagliata, Robert S Rahimi, Fatima Higuera-de-la-Tijera, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Digestive Diseases and Sciences|March 23, 2016
Amoxicillin-Clavulanate-Induced Liver InjuryAndrew S deLemos, Marwan Ghabril, Don C Rockey, et al.
Journal of Gastroenterology and Hepatology|December 23, 2025
Modern Diets, Metabolic Inequity, and Race-Ethnic Disparities: Unraveling the Associations With MASLD and Cancer RiskArunkumar Krishnan, Kunal C Kadakia, Sean Richard Rudnick, et al.
Human Gene Therapy|December 29, 2017
Adeno-Associated Virus Serotype 2 Vector-Mediated Reintroduction of microRNA-19b Attenuates Hepatic FibrosisElizabeth Brandon-Warner, Jennifer H Benbow, Jacob H Swet, et al.
Molecular and Cellular Biology|November 14, 2007
Parvin-beta inhibits breast cancer tumorigenicity and promotes CDK9-mediated peroxisome proliferator-activated receptor gamma 1 phosphorylationCameron N Johnstone, Perry S Mongroo, A Sophie Rich, et al.
Digestive Diseases and Sciences|January 14, 2018
Analysis of Plasma Tenascin-C in Post-HCV Cirrhosis: A Prospective StudyJennifer H Benbow, April D Elam, Krista L Bossi, et al.
World Journal of Hepatology|March 22, 2017
Risk factors for hepatocellular carcinoma in cirrhosis due to nonalcoholic fatty liver disease: A multicenter, case-control studyKathleen E Corey, Samer Gawrieh, Andrew S deLemos, et al.
Journal of Hepatology|September 6, 2021
Proof-of-concept study to evaluate the safety and efficacy of saroglitazar in patients with primary biliary cholangitisRaj Vuppalanchi, Stephen H Caldwell, Nikolaos Pyrsopoulos, et al.
The American Journal of Pathology|November 26, 2015
Diet-Induced Obesity Enhances Progression of Hepatocellular Carcinoma through Tenascin-C/Toll-Like Receptor 4 SignalingJennifer H Benbow, Kyle J Thompson, Heidi L Cope, et al.
Science Translational Medicine|November 22, 2013
Pharmacological inhibition of a microRNA family in nonhuman primates by a seed-targeting 8-mer antimiRVeerle Rottiers, Susanna Obad, Andreas Petri, et al.
Gastroenterology|June 4, 2023
Procedural-Related Bleeding in Hospitalized Patients With Liver Disease (PROC-BLeeD): An International, Prospective, Multicenter Observational StudyNicolas M Intagliata, Robert S Rahimi, Fatima Higuera-de-la-Tijera, et al.
Pageof 3